HemaSphere
(Jun 2022)
P777: RUNX1 VARIANTS WITH HIGH VARIANT ALLELE FREQUENCY IN MYELOID NEOPLASMS. GERMLINE OR NOT?
- N. J. Nitschke,
- M. Krogh,
- K. Raaschou-Jensen,
- M. T. Severinsen,
- A. S. Roug,
- J. S. Jespersen,
- J. W. Hansen,
- J. Weischenfeldt,
- M. K. Andersen,
- K. Grønbæk
Affiliations
- N. J. Nitschke
- 1 Department of Hematology, Rigshospitalet
- M. Krogh
- 3 Department of Hematology, Sjælland University Hospital, Roskilde
- K. Raaschou-Jensen
- 4 Department of Hematology, Odense University Hospital, Odense
- M. T. Severinsen
- 5 Department of Hematology and Clinical Cancer Research, Aalborg University Hospita, Aalborg
- A. S. Roug
- 6 Department of Clinical Medicine, Aarhus University Hospital, Aarhus
- J. S. Jespersen
- 2 Biotech Research and Innovation Center (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen
- J. W. Hansen
- 1 Department of Hematology, Rigshospitalet
- J. Weischenfeldt
- 2 Biotech Research and Innovation Center (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen
- M. K. Andersen
- 7 Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark
- K. Grønbæk
- 1 Department of Hematology, Rigshospitalet
- DOI
-
https://doi.org/10.1097/01.HS9.0000845992.27176.7c
- Journal volume & issue
-
Vol. 6
pp.
672
– 673
WeChat QR code